Cefepime vs. Piperacillin-Tazobactam for Infection?  The ACORN Trial

June 07, 2024 00:22:24
Cefepime vs. Piperacillin-Tazobactam for Infection?  The ACORN Trial
Critical Care Perspectives in Emergency Medicine
Cefepime vs. Piperacillin-Tazobactam for Infection?  The ACORN Trial

Jun 07 2024 | 00:22:24

/

Show Notes

Timely and appropriate administration of empiric broad-spectrum antibiotics for adult patients with sepsis is critical.  Current guidelines recommend an antipseudomonal antibiotic for those at risk of a resistant gram-negative organism.  The two most common antipseudomonal antibiotics prescribed in this setting are cefepime and piperacillin-tazobactam.  In recent years, observational studies have reported an association with cefepime and neurotoxicity, whereas piperacillin-tazobactam has been associated with AKI especially when given with vancomycin.  In this podcast, we discuss the recently published ACORN Trial, a randomized trial that evaluated cefepime and piperacillin-tazobactam for adult patients with suspected infection.

Other Episodes

Episode 0

July 02, 2020 00:46:15
Episode Cover

Updates in the Critical Care Management of COVID-19 Patients

There has been an explosion of literature on the evaluation and management of patients with COVID-19 infection.  In this podcast, we discuss updates (as...

Listen

Episode 0

June 17, 2022 00:37:25
Episode Cover

Life-Threatening Asthma

Approximately 2 million patients present each year to EDs in the United States for acute asthma exacerbations.  Of these, up to 50,000 may require...

Listen

Episode

December 29, 2023 00:24:55
Episode Cover

Should We Intubate For GCS < 8?

Acute mental status changes after the ingestion of alcohol or other substances are a common presentation to the ED.  Those with severe obtundation may...

Listen